Honliv Healthcare Management Group Company Limited
Honliv Healthcare Management Group Company Limited Fundamental Analysis
Honliv Healthcare Management Group Company Limited (9906.HK) shows weak financial fundamentals with a PE ratio of 71.23, profit margin of 1.49%, and ROE of 1.85%. The company generates $0.8B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 32.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 9906.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak9906.HK struggles to generate sufficient returns from assets.
Valuation Score
Moderate9906.HK shows balanced valuation metrics.
Growth Score
Moderate9906.HK shows steady but slowing expansion.
Financial Health Score
Excellent9906.HK maintains a strong and stable balance sheet.
Profitability Score
Moderate9906.HK maintains healthy but balanced margins.
Key Financial Metrics
Is 9906.HK Expensive or Cheap?
P/E Ratio
9906.HK trades at 71.23 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, 9906.HK's PEG of -1.22 indicates potential undervaluation.
Price to Book
The market values Honliv Healthcare Management Group Company Limited at 1.34 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 10.65 times EBITDA. This signals the market has high growth expectations.
How Well Does 9906.HK Make Money?
Net Profit Margin
For every $100 in sales, Honliv Healthcare Management Group Company Limited keeps $1.49 as profit after all expenses.
Operating Margin
Core operations generate 3.15 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $1.85 in profit for every $100 of shareholder equity.
ROA
Honliv Healthcare Management Group Company Limited generates $1.17 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Honliv Healthcare Management Group Company Limited produces operating cash flow of $117.91M, showing steady but balanced cash generation.
Free Cash Flow
Honliv Healthcare Management Group Company Limited generates strong free cash flow of $86.77M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.14 in free cash annually.
FCF Yield
9906.HK converts 9.55% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
71.23
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-1.22
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.34
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.17
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.25
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.03
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.02
vs 25 benchmark
ROA
Return on assets percentage
0.01
vs 25 benchmark
ROCE
Return on capital employed
0.04
vs 25 benchmark
How 9906.HK Stacks Against Its Sector Peers
| Metric | 9906.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 71.23 | 28.54 | Worse (Expensive) |
| ROE | 1.85% | 738.00% | Weak |
| Net Margin | 1.49% | -43982.00% (disorted) | Weak |
| Debt/Equity | 0.25 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 1.03 | 2806.01 | Neutral |
| ROA | 1.17% | -14624.00% (disorted) | Weak |
9906.HK outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Honliv Healthcare Management Group Company Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation